Phase I trial of INCB 47986 in healthy volunteers.
Latest Information Update: 28 Mar 2014
At a glance
- Drugs INCB 47986 (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Incyte Corporation
Most Recent Events
- 28 Mar 2014 New trial record